DK0610698T3 - Substituerede imidazo[4,5-b]pyridiner og benzimidazoler som angiotensin II-antagonister - Google Patents

Substituerede imidazo[4,5-b]pyridiner og benzimidazoler som angiotensin II-antagonister

Info

Publication number
DK0610698T3
DK0610698T3 DK94100846T DK94100846T DK0610698T3 DK 0610698 T3 DK0610698 T3 DK 0610698T3 DK 94100846 T DK94100846 T DK 94100846T DK 94100846 T DK94100846 T DK 94100846T DK 0610698 T3 DK0610698 T3 DK 0610698T3
Authority
DK
Denmark
Prior art keywords
benzimidazoles
pyridines
angiotensin
antagonists
substituted imidazo
Prior art date
Application number
DK94100846T
Other languages
English (en)
Inventor
Siegfried Dr Zaiss
Stefan Dr Wohlfeil
Andreas Dr Knorr
Juergen Dr Dressel
Peter Dr Fey
Walter Dr Huebsch
Thomas Dr Kraemer
Ulrich E Dr Mueller
Martin Dr Beuck
Stanislav Prof Dr Kazda
Johannes-Peter Dr Stasch
Matthias Dr Mueller-Gliemann
Rudolf H Dr Hanko
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0610698T3 publication Critical patent/DK0610698T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK94100846T 1993-02-03 1994-01-21 Substituerede imidazo[4,5-b]pyridiner og benzimidazoler som angiotensin II-antagonister DK0610698T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4302956A DE4302956A1 (de) 1993-02-03 1993-02-03 Substituierte Imidazo(4,5-b)pyridine und Benzimidazole

Publications (1)

Publication Number Publication Date
DK0610698T3 true DK0610698T3 (da) 2001-06-18

Family

ID=6479486

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94100846T DK0610698T3 (da) 1993-02-03 1994-01-21 Substituerede imidazo[4,5-b]pyridiner og benzimidazoler som angiotensin II-antagonister

Country Status (9)

Country Link
US (1) US5527809A (da)
EP (1) EP0610698B1 (da)
JP (1) JPH06247968A (da)
AT (1) ATE201207T1 (da)
DE (2) DE4302956A1 (da)
DK (1) DK0610698T3 (da)
ES (1) ES2158868T3 (da)
GR (1) GR3036287T3 (da)
PT (1) PT610698E (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4443891A1 (de) * 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
DE19525028A1 (de) * 1995-07-10 1997-01-16 Bayer Ag Amide und Sulfonamide von heterocyclisch substituierten Benzylaminen
DE19535504A1 (de) * 1995-09-25 1997-03-27 Bayer Ag Substituierte Xanthine
DE19536378A1 (de) * 1995-09-29 1997-04-03 Bayer Ag Heterocyclische Aryl-, Alkyl- und Cycloalkylessigsäureamide
DE19546919A1 (de) 1995-12-15 1997-06-19 Bayer Ag N-Heterocyclisch substituierte Phenylessigsäure-Derivate
DE19546918A1 (de) * 1995-12-15 1997-06-19 Bayer Ag Bicyclische Heterocyclen
DE19613550A1 (de) * 1996-04-04 1997-10-09 Bayer Ag Neue Pyrimido[1,2-a]indole
US6774236B1 (en) 1996-04-04 2004-08-10 Bayer Aktiengesellschaft Process for the preparation of enantiomerically pure cycloalkano-indol -and azaindol -and pyrimido [1,2A]indolcarbocyclic acids and their activated derivatives
DE19613549A1 (de) * 1996-04-04 1997-10-09 Bayer Ag Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate
DE19619950A1 (de) 1996-04-17 1997-10-23 Bayer Ag Heterocyclisch-substituierte Phenylglycinolamide
EP0802192A1 (de) * 1996-04-17 1997-10-22 Bayer Ag Heterocyclisch-substituierte Phenylglycinolamide mit antiatherosklerotischer Wirkung und Verfahren zu ihrer Herstellung
DE19615119A1 (de) 1996-04-17 1997-10-23 Bayer Ag Neue Arylessigsäureamide
CN104072425B (zh) * 2014-07-09 2016-12-07 大连理工大学 苯并咪唑类化合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
GB8911854D0 (en) * 1989-05-23 1989-07-12 Ici Plc Heterocyclic compounds
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
EP0515548A4 (en) * 1990-02-13 1993-03-10 Merck & Co. Inc. Imidazole angiotensin ii antagonists incorporating a substituted benzyl element
US5240938A (en) * 1991-02-13 1993-08-31 Merck & Co., Inc. Angiotensin II antagonists incorporating a substituted pyridoimidazolyl ring
CA2075627A1 (en) * 1990-02-13 1991-08-14 William J. Greenlee Angiotensin ii antagonists incorporating a substituted benzyl element
DE4200954A1 (de) * 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate

Also Published As

Publication number Publication date
ES2158868T3 (es) 2001-09-16
EP0610698A3 (en) 1994-09-14
GR3036287T3 (en) 2001-10-31
EP0610698A2 (de) 1994-08-17
PT610698E (pt) 2001-08-30
DE4302956A1 (de) 1994-08-04
DE59409747D1 (de) 2001-06-21
ATE201207T1 (de) 2001-06-15
JPH06247968A (ja) 1994-09-06
EP0610698B1 (de) 2001-05-16
US5527809A (en) 1996-06-18

Similar Documents

Publication Publication Date Title
DK0624583T3 (da) Substituerede pyridylmethylpyridoner som angiotensin II-antagonister
TR199700213A2 (xx) 2-Aril s�bstit�entli piridinler.
DK0610698T3 (da) Substituerede imidazo[4,5-b]pyridiner og benzimidazoler som angiotensin II-antagonister
MY129973A (en) Sulphonylbenzyl-substituted pyridones.
DE69232323D1 (de) Verwendung von Adenosinantagonisten zur Vorbeugung und Behandlung von Pankreatitis und Ulcera
DK61491D0 (da) Pyrro(1,2-a)imidazol- og imidazo(1,2-a)pyridinderivater
ES2181853T3 (es) Tratamiento del tinnitus empleando agentes neuroprotectores.
MY131595A (en) Heterocyclically substituted phenyl-cyclohexane- carboxylic acid derivatives
DE69503066D1 (de) KRISTALLFORM VON WASSERFREIEN 7-((1a,5a,6a)-6-AMINO-3-AZABICYCLO (3.1.0.) HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDIN-CARBONSÄURE METHANESULFONSÄURE SALZ
IS2819B (is) Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra
NO991624D0 (no) 1H-pyrido[3,4-b]indol-4-karboksamid-derivater, fremstilling og anvendelse derav i terapeutiske midler
DE60204755D1 (de) "3,7-diazabicyclo(3.3.0)octane und deren verwendung bei der behandlung von herzrhythmusstörungen"
FI972684L (fi) Piperidiinietikkahappojohdannaisia, joita voidaan käyttää fibrinogeeniantagonisteina
FI973273L (fi) Bisykliset isotioureajohdannaiset, jotka ovat käyttökelpoisia terapiassa
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
TR28873A (tr) N-sübstitüe edilmis, N,N'-kaynasik heterosiklik benzoik asit üretmeye mahsus yöntem.
EP0672052A1 (en) TACHYQUININE ANTAGONISTS, THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL FORMULATIONS.
ATE150018T1 (de) Imidazolyl-substituierte phenylessigsäureprolinamide
FI945164A7 (fi) Biologisesti aktiivisesti ureidojohdannaiset, jotka ovat käyttökelpoisia antimetastaattisina aineina
DK0617035T3 (da) Hetero-tricyclisk-substituerede phenyl-cyclohexan-carboxylsyrederivater.
EA199900020A2 (ru) Способ получения нафтиридонов и промежуточных соединений
ATE167478T1 (de) Kristallform von wasserfreien 7-((1a,5a,6a)-6- amino-3-azabicyclo (3.1.0.) hex-3-yl)-6-fluoro-1- (2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8- naphthyridin-carbonsäure methanesulfonsäure salz